14-day Premium Trial Subscription Try For FreeTry Free
$4.47
-0.250 (-5.30%)
At Close: May 17, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Oct 27, 2023 Buy 49 500 Goodman Gerald Stock Option
Mar 06, 2023 Sell 5 000 Melnik Serguei Common Stock, par value $0.001 per share
Dec 09, 2022 Buy 20 000 Goodman Gerald Stock Option
Aug 16, 2022 Buy 23 333 Goodman Gerald Stock Option
May 10, 2022 Buy 10 000 Sheridan Gareth Common Stock
May 10, 2022 Sell 10 000 Sheridan Gareth Common Stock
Feb 24, 2022 Buy 500 Melnik Serguei Common Stock, par value $0.001 per share
Feb 24, 2022 Sell 500 Melnik Serguei Common Stock, par value $0.001 per share
Feb 24, 2022 Sell 5 000 Melnik Serguei Common Stock, par value $0.001 per share
Feb 06, 2022 Sell 10 000 Melnik Serguei Common Stock, par value $0.001 per share
Jan 21, 2022 Buy 11 167 Goodman Gerald Stock Option
Jan 21, 2022 Buy 23 333 Melnik Serguei Options to Purchase Common Stock
Jan 21, 2022 Buy 23 333 Sheridan Gareth Options to Purchase Common Stock
Jan 21, 2022 Buy 20 000 Melnik Serguei Options to Purchase Common Stock
Jan 21, 2022 Buy 20 000 Sheridan Gareth Options to Purchase Common Stock
Oct 22, 2021 Buy 87 500 Goodman Gerald CS Purchase Warrant
Jan 31, 2021 Buy 0 Sheridan Gareth
May 30, 2019 Sell 20 000 Melnik Serguei Common Stock, par value $0.001 per share
Jul 31, 2018 Buy 5 000 Davidov Michael Common Stock, par value $0.001 per share
May 31, 2018 Buy 0 Davidov Michael
Jan 31, 2018 Sell 0 Melnik Serguei Common Stock, par value $0. 001 per share
Jan 31, 2018 Buy 0 Melnik Serguei Common Stock, par value $0.001 per share
Jan 31, 2018 Buy 0 Melnik Serguei Common Stock, par value $0.001 per share
Jan 31, 2018 Buy 0 Sheridan Gareth
Aug 19, 2017 Sell 450 000 Melnik Serguei Common Stock
Aug 17, 2017 Sell 1 000 000 Sheridan Gareth Common Stock
Jan 31, 2017 Buy 0 Melnik Serguei
Jan 31, 2017 Buy 0 Botgros Vitalie
Jan 31, 2017 Buy 0 Sheridan Gareth
JSON CSV
INSIDER POWER
65.952
Last 29 transactions
Buy: 293 666 | Sell: 1 500 500 (Shares)

Based on the 29 latest insides trades, we have calculated the insider power to be positive at a ratio of 65.952.

In total, the insiders bought 293 666 and sold 1 500 500 NTRB shares in the last 29 trades.

Click to get the best stock tips daily for free!

About Nutriband Inc.

Nutriband. Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; e... NTRB Profile

Golden Star

Ticker Date Change Price
LYV May 15 0.114% $96.48
RL May 15 0.539% $166.98
PAGS May 15 0.157% $12.74
EVBG May 15 0.230% $34.79
INBX May 15 0.96% $34.37
CME May 14 1.11% $210.80
VGIT May 14 0.173% $57.83
VCLT May 14 0.726% $75.73
BNDX May 14 0.267% $48.60
FIXD May 14 0.303% $42.89
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT